Angelo Ghirarduzzi Selected Research

Obesity

6/2010

Comorbidities, alone and in combination with D-dimer, as risk factors for recurrence after a first episode of unprovoked venous thromboembolism in the extended follow-up of the PROLONG study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Angelo Ghirarduzzi Research Topics

Disease

13	Venous Thrombosis (Deep-Vein Thrombosis) 02/2024 - 04/2004
13	Venous Thromboembolism 01/2018 - 10/2006
8	Thrombosis (Thrombus) 08/2023 - 07/2007
6	Pulmonary Embolism 01/2016 - 10/2006
5	Hemorrhage 01/2021 - 09/2002
4	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 08/2023 - 12/2007
3	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 06/2010
3	Neoplasms (Cancer) 11/2014 - 11/2009
3	Thromboembolism 02/2014 - 10/2006
2	Myocardial Infarction 01/2018 - 03/2010
2	Ischemic Stroke 01/2018 - 07/2007
2	Atrial Fibrillation 01/2018 - 01/2017
2	Embolism (Embolus) 01/2017 - 07/2007
2	Vascular Diseases (Vascular Disease) 06/2010 - 11/2005
1	Neglected Diseases 11/2023
1	Pregnancy Complications 08/2023
1	Infections 08/2023
1	Hemophilia A (Haemophilia) 01/2022
1	Pheochromocytoma 01/2020
1	Polycythemia (Erythrocytosis) 01/2020
1	Paraganglioma (Paragangliomas) 01/2020
1	Headache (Headaches) 01/2020
1	Fatigue 01/2020
1	Stroke (Strokes) 01/2017
1	Varicose Veins (Varicose Vein) 02/2014
1	Obesity 06/2010
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 06/2010
1	Hypertension (High Blood Pressure) 06/2010
1	Chronic Obstructive Pulmonary Disease (COPD) 06/2010
1	Clinical Deterioration 03/2010
1	Retinal Vein Occlusion 02/2010
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2005

Drug/Important Bio-Agent (IBA)

10	fibrin fragment D (D-dimer)IBA 01/2016 - 10/2006
6	AnticoagulantsIBA 02/2024 - 09/2002
5	Warfarin (Coumadin)FDA LinkGeneric 02/2024 - 01/2017
5	Vitamin K FDA Link 08/2023 - 10/2006
3	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 02/2024 - 02/2014
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 08/2023 - 02/2010
3	factor V LeidenIBA 03/2013 - 04/2004
3	Prothrombin (Factor II)IBA 03/2013 - 04/2004
2	Heparin (Liquaemin)FDA LinkGeneric 08/2023 - 03/2010
2	RivaroxabanIBA 01/2021 - 01/2018
2	parnaparinIBA 02/2014 - 02/2010
2	SuspensionsIBA 06/2010 - 01/2010
2	Fumigant 93 (D-D)IBA 01/2010 - 11/2009
1	Factor XI (Plasma Thromboplastin Antecedent)IBA 11/2023
1	Prednisolone (Predate)FDA LinkGeneric 08/2023
1	Intravenous Immunoglobulins (IVIG)FDA Link 08/2023
1	Antiphospholipid AntibodiesIBA 08/2023
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 08/2023
1	AutoantibodiesIBA 01/2022
1	BNT162 VaccineIBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Factor VIII (Coagulation Factor VIII)IBA 01/2022
1	Dabigatran FDA Link 01/2021
1	EnzymesIBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	Chromogranin AIBA 01/2020
1	Erythropoietin FDA Link 01/2020
1	Hemoglobins (Hemoglobin)IBA 01/2020
1	edoxabanIBA 01/2017
1	FluxumIBA 02/2014
1	TESIBA 10/2011
1	Tenecteplase FDA Link 03/2010
1	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 12/2007
1	2,5-dichloro-4-bromophenol (B 2)IBA 07/2007
1	HomocysteineIBA 11/2005
1	Factor V (Coagulation Factor V)IBA 04/2004

Therapy/Procedure

4	Therapeutics 08/2023 - 12/2007
1	Adrenalectomy 01/2020
1	Aftercare (After-Treatment) 12/2007